89bio, Inc. ETNB
Set alert
14.84 0.00 0.00%
At close · Oct 30
14.84 Day range 14.84
52-week range unavailable
- YTD
- +89.77%
- 1 year
- +85.73%
- Open
- 14.84
- Prev close
- 14.84
- Mkt cap
- 2.20B
- Vol
- 38.51M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 14.84
- High
- 14.84
- Forward P/E
- -5.17
- Beta
- 1.26
- Short ratio
- 0.74
- Inst. own
- 103.69%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 12.52
- 200-d avg
- 9.87
- 1y target
- 30.38
Analyst view
Consensus: buy
Buy
Price target (mean) 30.38 +104.7% upside
Now 14.84
- Target (low)
- 14.50
- Target (mean)
- 30.38
- Target (high)
- 55.00
Ratings (0m) 6 2 buy · 4 hold · 0 sell
- Strong buy0
- Buy2
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 8
- 2 months ago 10
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.49667 | -0.53 – -0.44 | -1.39 | +64.3% | 0 | 0.0% | 6 |
| Next quarter | -0.52833 | -0.63 – -0.45 | -1.02 | +48.2% | 0 | 0.0% | 6 |
| Current year | -2.21 | -2.35 – -2.08 | -3.51 | +37.0% | 0 | 0.0% | 6 |
| Next year | -2.34 | -2.65 – -1.74 | -2.21 | -5.7% | 0 | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 19, 2025 | Raymond James | Downgrade | Outperform | Market Perform |
| Sep 19, 2025 | Wolfe Research | Downgrade | Outperform | Peer Perform |
| Sep 19, 2025 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Aug 25, 2025 | B of A Securities | Maintained | Buy | Buy |
| Aug 8, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Mar 14, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Mar 13, 2025 | Citigroup | Initiated | — | Buy |
| Feb 28, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 4, 2025 | Wolfe Research | Initiated | — | Outperform |
| Jan 31, 2025 | UBS | Maintained | Buy | Buy |
| Jan 21, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 2, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 8, 2024 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Sep 20, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 6, 2024 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Aug 6, 2024 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Aug 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 1, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 17, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 12, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 17, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| May 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 10, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 5, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 27, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |